Acta Oncologica, Volume 60, Issue 4 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Acta Oncologica, Volume 60, Issue 4 (2021)

See all volumes and issues
Vol 62, 2023 Vol 61, 2022 Volume 60, 2021 Vol 59, 2020 Vol 58, 2019 Vol 57, 2018 Vol 56, 2017 Vol 55, 2016 Vol 54, 2015 Vol 53, 2014 Vol 52, 2013 Vol 51, 2012 Vol 50, 2011 Vol 49, 2010 Vol 48, 2009 Vol 47, 2008 Vol 46, 2007 Vol 45, 2006 Vol 44, 2005 Vol 43, 2004 Vol 42, 2003 Vol 41, 2002 Vol 40, 2001 Vol 39, 2000 Vol 38, 1999 Vol 37, 1998 Vol 36, 1997 Vol 35, 1996 Vol 34, 1995 Vol 33, 1994 Vol 32, 1993 Vol 31, 1992 Vol 30, 1991 Vol 29, 1990 Vol 28, 1989 Vol 27, 1988 Vol 26, 1987 Vol 25, 1986 Vol 24, 1985 Vol 23, 1984 Vol 22, 1983 Vol 21, 1982 Vol 20, 1981 Vol 19, 1980 Vol 18, 1979 Vol 17, 1978 Vol 16, 1977 Vol 15, 1976 Vol 14, 1975 Vol 13, 1974 Vol 12, 1973 Vol 11, 1972 Vol 10, 1971 Vol 9, 1970 Vol 8, 1969 Vol 7, 1968 Vol 6, 1967 Vol 5, 1966 Vol 4, 1966 Vol 3, 1965 Vol 2, 1964 Vol 1, 1963
Download citations Download PDFs Download issue

Editorial

Editorial
Look at the compass needle and see your course – navigation as a cancer survivor
Christoffer Johansen & Susanne O. Dalton
Pages: 401-402
Published online: 01 Mar 2021
CitationforLook at the compass needle and see your course – navigation as a cancer survivor | Full Text | References | PDF (236.4 KB) | EPUB
  • 807 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Articles: Rehabilitation and Survivorship

Article
The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?
A. van der Hout, K. Holtmaat, F. Jansen, B. I. Lissenberg-Witte, C. F. van Uden-Kraan, G. A. P. Nieuwenhuijzen, J. A. Hardillo, R. J. Baatenburg de Jong, N. L. Tiren-Verbeet, D. W. Sommeijer, K. de Heer, C. G. Schaar, R. J. E. Sedee, K. Bosscha, M. W. M. van den Brekel, J. F. Petersen, M. Westerman, J. Honings, R. P. Takes, I. Houtenbos, W. T. van den Broek, R. de Bree, P. Jansen, S. E. J. Eerenstein, C. R. Leemans, J. M. Zijlstra, P. Cuijpers, L. V. van de Poll-Franse & I. M. Verdonck-de Leeuw
Pages: 403-411
Published online: 21 Dec 2020
AbstractforThe eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? | Full Text | References | PDF (3 MB) | EPUB | Supplemental
  • 5618 Views
  • 27 CrossRef citations
  • 0Altmetric
Open Access
Article
Taxane-induced pain in breast cancer patients as perceived by nurses
Susanne Hellerstedt-Börjesson, Karin Nordin, Marie-Louise Fjällskog, Magnus Peterson & Cecilia Arving
Pages: 412-418
Published online: 10 Feb 2021
AbstractforTaxane-induced pain in breast cancer patients as perceived by nurses | Full Text | References | PDF (598.4 KB) | EPUB
  • 1333 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment
Dag Rune Stormoen, Christina Baeksted, Gry Assam Taarnhøj, Christoffer Johansen & Helle Pappot
Pages: 419-425
Published online: 27 Feb 2021
AbstractforPatient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1135 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
J. Skalleberg, M. Myhrum, M. C. Småstuen, T. A. Osnes, S. D. Fosså & M. Bunne
Pages: 426-433
Published online: 22 Feb 2021
AbstractforSpeech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity? | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 830 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness
Anette Stolberg Kargo, Pernille Tine Jensen, Kristina Lindemann, Niels Henrik Ingvar Hjollund, Bente Lund, Mette Haee, Sören Möller, Dorte Gilså Hansen & Karina Dahl Steffensen
Pages: 434-443
Published online: 02 Mar 2021
AbstractforThe PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 1667 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Cancer Epidemiolog

Article
Management of low-grade cervical cytology in young women. Cohort study from Denmark
Gry St-Martin, Lise Holst Thamsborg, Berit Andersen, Jette Christensen, Dorthe Ejersbo, Kirsten Jochumsen, Tonje Johansen, Lise Grupe Larsen, Marianne Waldstrøm & Elsebeth Lynge
Pages: 444-451
Published online: 08 Oct 2020
AbstractforManagement of low-grade cervical cytology in young women. Cohort study from Denmark | Full Text | References | PDF (751 KB) | EPUB | Supplemental
  • 2952 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Identification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries
Linda A. Rasmussen, Henry Jensen, Line F. Virgilsen, Mette M. Jeppesen, Jan Blaakaer, Dorte G. Hansen, Pernille T. Jensen, Ole Mogensen & Peter Vedsted
Pages: 452-458
Published online: 11 Dec 2020
AbstractforIdentification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1236 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden
Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck & Pär Stattin
Pages: 459-465
Published online: 19 Feb 2021
AbstractforRisk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1810 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Medical Oncology

Article
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide
Patrice Chevallier, Ana Berceanu, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Berthe-Marie Imbert, Etienne Daguindau, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Benoît Tessoulin, Sophie Vantyghem, Yohan Desbrosses, Céline Bressollette, Alix Duquesne, Marion Eveillard, Yannick Le Bris, Anne Dormoy, Caroline Malugani, Eric Deconinck, Philippe Moreau, Steven Le Gouill, Marie C. Béné & Thierry Guillaume
Pages: 466-474
Published online: 28 Oct 2020
AbstractforGrade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide | Full Text | References | PDF (961.6 KB) | EPUB
  • 1658 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab
Anton E. Andersson, Barbro Linderholm & Daniel Giglio
Pages: 475-481
Published online: 16 Nov 2020
AbstractforDelta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab | Full Text | References | PDF (840.2 KB) | EPUB | Supplemental
  • 1998 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort
Siavash Foroughi, Hui-li Wong, Jeanne Tie, Rachel Wong, Margaret Lee, Belinda Lee, Ian Jones, Iain Skinner, Antony W. Burgess & Peter Gibbs
Pages: 482-490
Published online: 30 Dec 2020
AbstractforCharacteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 904 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study
Jakob Schmidt Jensen, Kathrine Kronberg Jakobsen, Christian Mirian, Mustafa Ghanizada, Katrin Håkansson, Irene Wessel, Christian Grønhøj, Jacob Høygaard Rasmussen & Christian von Buchwald
Pages: 491-496
Published online: 26 Dec 2020
AbstractforImpact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study | Full Text | References | PDF (736 KB) | EPUB | Supplemental
  • 706 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study
Ali Al-Kaabi, Rachel S. van der Post, Leonie R. van der Werf, Bas P. L. Wijnhoven, Camiel Rosman, Maarten C. C. M. Hulshof, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven & Peter D. Siersema
Pages: 497-504
Published online: 25 Jan 2021
AbstractforImpact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 2662 Views
  • 27 CrossRef citations
  • 0Altmetric
Open Access
Article
Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients
Animesh Saha, Matthew Beasley, Nathaniel Hatton, Peter Dickinson, Kevin Franks, Katy Clarke, Pooja Jain, Mark Teo, Patrick Murray & John Lilley
Pages: 505-512
Published online: 24 Jan 2021
AbstractforCan dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1064 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS)
Johannes Asplund, Eivind Gottlieb-Vedi, Wilhelm Leijonmarck, Fredrik Mattsson & Jesper Lagergren
Pages: 513-520
Published online: 27 Jan 2021
AbstractforPrognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS) | Full Text | References | PDF (1.1 MB) | EPUB
  • 1419 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting
Thomas Ringgaard Petersen, Vasiliki Panou, Christos Meristoudis, Ulla Møller Weinreich & Oluf Dimitri Røe
Pages: 521-527
Published online: 27 Jan 2021
AbstractforClinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting | Full Text | References | PDF (1.1 MB) | EPUB
  • 1446 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia
Ferenc Takács, Gábor Mikala, Noémi Nagy, Andrea Reszegi, Ágnes Czeti, Gábor Szalóki & Gábor Barna
Pages: 528-530
Published online: 25 Jan 2021
AbstractforIdentification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1186 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
Maysaa Abdulla, Andrei Alexsson, Christer Sundström, Claes Ladenvall, Larry Mansouri, Cecilia Lindskog, Mattias Berglund, Lucia Cavelier, Gunilla Enblad, Peter Hollander & Rose-Marie Amini
Pages: 531-538
Published online: 12 Feb 2021
AbstractforPD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 2178 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor: Medical Oncology

Letter
Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)
Midas B. Mulder, Erwin Birnie, Caroline van Dijck – van Boetzelaer, Gert-Jan van de Geijn, Egbert Boevé, Elsbeth M. Westerman & Paul Hamberg
Pages: 539-543
Published online: 26 Dec 2020
First Page PreviewforUnsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial) | Full Text | References | PDF (704.7 KB) | EPUB | Supplemental
  • 772 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Letter
Immune cell score, PD-L1 expression and prognosis in esophageal cancer
Anna Junttila, Juha P. Väyrynen, Maarit Ahtiainen, Teijo Kuopio, Johanna Mrena, Eero Sihvo & Olli Helminen
Pages: 544-548
Published online: 13 Jan 2021
First Page PreviewforImmune cell score, PD-L1 expression and prognosis in esophageal cancer | Full Text | References | PDF (740.7 KB) | EPUB | Supplemental
  • 2630 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Letter
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
Giacomo Bregni, Caroline Vandeputte, Andrea Pretta, Chiara Senti, Elena Trevisi, Elena Acedo Reina, Pashalina Kehagias, Gabriel Liberale, Luigi Moretti, Maria Antonietta Bali, Pieter Demetter, Patrick Flamen, Javier Carrasco, Lionel D'Hondt, Karen Geboes, Yeter Gokburun, Marc Peeters, Marc Van den Eynde, Jean-Luc Van Laethem, Philippe Vergauwe, Camille Anastasia Chapot, Marc Buyse, Amelie Deleporte, Alain Hendlisz & Francesco Sclafani
Pages: 549-553
Published online: 13 Jan 2021
First Page PreviewforRationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer | Full Text | References | PDF (760.3 KB) | EPUB | Supplemental
  • 1634 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Letter
Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma
Valtteri Kairaluoma, Niko Kemi, Heikki Huhta, Vesa-Matti Pohjanen & Olli Helminen
Pages: 554-558
Published online: 27 Jan 2021
First Page PreviewforPrognostic role of TLR4 and TLR2 in hepatocellular carcinoma | Full Text | References | PDF (630.2 KB) | EPUB | Supplemental
  • 1300 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Letter
Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community
Tracy Ngo, Claudia Hossain, Anthony K. Guzman, Balazs Halmos, Yevgeniy Balagula & Beth McLellan
Pages: 559-563
Published online: 01 Feb 2021
First Page PreviewforSpectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community | Full Text | References | PDF (828.9 KB) | EPUB
  • 1339 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Commentry

Article Commentary
Comment on ‘Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab’
Mehmet Zahid Kocak
Pages: 564-565
Published online: 20 Feb 2021
CitationforComment on ‘Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab’ | Full Text | References | PDF (344.9 KB) | EPUB
  • 384 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles